Tirzepatide, a groundbreaking drug, represents a significant innovation in the management of type 2 diabetes mellitus and, more recently, obesity. This dual activator acts upon two crucial receptors: glucagon-like peptide-1 and GIP. Unlike traditional medications for diabetes, Tirzepatide promotes not only insulin secretion when blood sugar are ele